Results 121 to 130 of about 3,507 (193)

Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Espinola N   +7 more
europepmc   +1 more source

[SARS-CoV-2 antibodies after booster vaccination. Identification of subgroups with poor response]. [PDF]

open access: yesRev Clin Esp, 2023
Ayuso García B   +6 more
europepmc   +1 more source

[Autoimmunity and Freiburg classification in common variable immunodeficiency]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc, 2023
Herrera-Sánchez DA   +5 more
europepmc   +1 more source

Recurrent Pericarditis After Covid-19. [PDF]

open access: yesReumatol Clin (Engl Ed), 2021
Rodrigo Domínguez D   +5 more
europepmc   +1 more source

[Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)]. [PDF]

open access: yesAn Sist Sanit Navar, 2022
Caso-González A   +5 more
europepmc   +1 more source

Nanopartículas para la artritis reumatoide

open access: yes, 2019
La artritis reumatoide (AR) es una enfermedad inflamatoria autoinmune asociada a la inflamación crónica de la membrana sinovial, lo que causa la destrucción del cartílago y el hueso circundante provocando dolor, rigidez, hinchazón e incluso la pérdida de la función articular, cuya etiopatogenia aún se desconoce, y es causante de discapacidad.
openaire   +1 more source

Home - About - Disclaimer - Privacy